"Adult" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Descriptor ID |
D000328
|
MeSH Number(s) |
M01.060.116
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Adult".
Below are MeSH descriptors whose meaning is more specific than "Adult".
This graph shows the total number of publications written about "Adult" by people in this website by year, and whether "Adult" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 234 | 234 |
1995 | 0 | 279 | 279 |
1996 | 0 | 300 | 300 |
1997 | 0 | 303 | 303 |
1998 | 0 | 315 | 315 |
1999 | 0 | 305 | 305 |
2000 | 0 | 397 | 397 |
2001 | 0 | 368 | 368 |
2002 | 0 | 424 | 424 |
2003 | 0 | 409 | 409 |
2004 | 0 | 460 | 460 |
2005 | 0 | 499 | 499 |
2006 | 0 | 550 | 550 |
2007 | 0 | 557 | 557 |
2008 | 0 | 657 | 657 |
2009 | 0 | 589 | 589 |
2010 | 0 | 638 | 638 |
2011 | 0 | 728 | 728 |
2012 | 0 | 755 | 755 |
2013 | 0 | 788 | 788 |
2014 | 0 | 763 | 763 |
2015 | 0 | 786 | 786 |
2016 | 0 | 847 | 847 |
2017 | 0 | 843 | 843 |
2018 | 0 | 881 | 881 |
2019 | 0 | 852 | 852 |
2020 | 0 | 803 | 803 |
2021 | 0 | 703 | 703 |
2022 | 0 | 319 | 319 |
2023 | 0 | 306 | 306 |
2024 | 0 | 46 | 46 |
To return to the timeline,
click here.
Below are the most recent publications written about "Adult" by people in Profiles.
-
Effects of Social Determinants and Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions. Ann Fam Med. 2024 Nov 01; 21(Suppl 3).
-
Ginkgolic acid inhibits orthopneumo- and metapneumo- virus infectivity. Sci Rep. 2024 04 08; 14(1):8230.
-
Angiographic Coronary Slow Flow Is Not a Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction. JACC Cardiovasc Interv. 2024 Apr 08; 17(7):920-929.
-
A Case Report of Fluoroscopically Guided Epidural Catheter Placement in a Parturient with History of Tethered Cord, Super-Morbid Obesity, and Risk for Difficult Airway. A A Pract. 2024 Apr 01; 18(4):e01777.
-
Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease-Risk Persons Living with HIV. Radiol Cardiothorac Imaging. 2024 Apr; 6(2):e230102.
-
Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis. JAMA. 2024 03 26; 331(12):1055-1056.
-
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials. BMJ Open. 2024 Mar 19; 14(3):e076444.
-
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial. Lancet. 2024 Mar 23; 403(10432):1141-1152.
-
Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial. Lancet. 2024 Mar 23; 403(10432):1153-1163.
-
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial. JAMA. 2024 03 05; 331(9):740-749.